Neurodegenerative Proteinopathies Induced by Environmental Pollutants: Heat Shock Proteins and Proteasome as Promising Therapeutic Tools

被引:2
作者
Moyano, Paula [1 ]
Sola, Emma [1 ]
Naval, Maria Victoria [2 ]
Guerra-Menendez, Lucia [3 ]
Fernandez, Maria De la Cabeza [4 ]
del Pino, Javier [1 ]
机构
[1] Univ Complutense Madrid, Vet Sch, Dept Pharmacol & Toxicol, Madrid 28040, Spain
[2] Univ Complutense Madrid, Pharm Sch, Dept Pharmacol Pharmacognosy & Bot, Madrid 28041, Spain
[3] San Pablo CEU Univ, Med Sch, Dept Physiol, Madrid 28003, Spain
[4] Univ Complutense Madrid, Pharm Sch, Dept Chem & Pharmaceut Sci, Madrid 28041, Spain
关键词
environmental pollutants; heat shock proteins; proteasome; proteinopathies; neurodegenerative diseases; AMYLOID PRECURSOR PROTEIN; NEURONAL CELL-DEATH; FOREBRAIN CHOLINERGIC NEURONS; SYNUCLEIN FIBRIL FORMATION; INDUCED OXIDATIVE STRESS; ACHE VARIANTS ALTERATION; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; HEME OXYGENASE-1;
D O I
10.3390/pharmaceutics15082048
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Environmental pollutants' (EPs) amount and diversity have increased in recent years due to anthropogenic activity. Several neurodegenerative diseases (NDs) are theorized to be related to EPs, as their incidence has increased in a similar way to human EPs exposure and they reproduce the main ND hallmarks. EPs induce several neurotoxic effects, including accumulation and gradual deposition of misfolded toxic proteins, producing neuronal malfunction and cell death. Cells possess different mechanisms to eliminate these toxic proteins, including heat shock proteins (HSPs) and the proteasome system. The accumulation and deleterious effects of toxic proteins are induced through HSPs and disruption of proteasome proteins' homeostatic function by exposure to EPs. A therapeutic approach has been proposed to reduce accumulation of toxic proteins through treatment with recombinant HSPs/proteasome or the use of compounds that increase their expression or activity. Our aim is to review the current literature on NDs related to EP exposure and their relationship with the disruption of the proteasome system and HSPs, as well as to discuss the toxic effects of dysfunction of HSPs and proteasome and the contradictory effects described in the literature. Lastly, we cover the therapeutic use of developed drugs and recombinant proteasome/HSPs to eliminate toxic proteins and prevent/treat EP-induced neurodegeneration.
引用
收藏
页数:30
相关论文
共 283 条
  • [1] Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE-NFκB and Nrf2 antioxidant signaling pathways
    Abdelsalam, Rania M.
    Safar, Marwa M.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2015, 133 (05) : 700 - 707
  • [2] Redox active metals in neurodegenerative diseases
    Acevedo, Karla
    Masaldan, Shashank
    Opazo, Carlos M.
    Bush, Ashley I.
    [J]. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2019, 24 (08): : 1141 - 1157
  • [3] Nanocarriers as Potential Drug Delivery Candidates for Overcoming the Blood-Brain Barrier: Challenges and Possibilities
    Ahlawat, Jyoti
    Barroso, Gileydis Guillama
    Asil, Shima Masoudi
    Alvarado, Melinda
    Armendariz, Isabela
    Bernal, Jose
    Carabaza, Ximena
    Chavez, Stephanie
    Cruz, Paulina
    Escalante, Vassti
    Estorga, Savana
    Fernandez, Daniel
    Lozano, Carolina
    Marrufo, Martin
    Ahmad, Nabeel
    Negrete, Sergio
    Olvera, Karyme
    Parada, Ximena
    Portillo, Brianna
    Ramirez, Andrea
    Ramos, Raul
    Rodriguez, Veronica
    Rojas, Paola
    Romero, Jessica
    Suarez, David
    Urueta, Graciela
    Viel, Stephanie
    Narayan, Mahesh
    [J]. ACS OMEGA, 2020, 5 (22): : 12583 - 12595
  • [4] Biomarker responses in juvenile rainbow trout (Oncorhynchus mykiss) after single and combined exposure to low doses of cadmium, zinc, PCB77 and 17β-oestradiol
    Aït-Aïssa, S
    Ausseil, O
    Palluel, O
    Vindimian, E
    Garnier-Laplace, J
    Porcher, JM
    [J]. BIOMARKERS, 2003, 8 (06) : 491 - 508
  • [5] CHIP protects from the neurotoxicity of expanded and wild-type ataxin-1 and promotes their ubiquitination and degradation
    Al-Ramahi, Ismael
    Lam, Yung C.
    Chen, Hung-Kai
    de Gouyon, Beatrice
    Zhang, Minghang
    Perez, Alma M.
    Branco, Joana
    de Haro, Maria
    Patterson, Cam
    Zoghbi, Huda Y.
    Botas, Juan
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (36) : 26714 - 26724
  • [6] Investigation of 8-OHdG, CYP1A, HSP70 and transcriptional analyses of antioxidant defence system in liver tissues of rainbow trout exposed to eprinomectin
    Alak, Gonca
    Yeltekin, Ash Cilingir
    Tas, Ismail Hakki
    Ucar, Arzu
    Parlak, Veysel
    Topal, Ahmet
    Kocaman, Esat Mahmut
    Atamanalp, Muhammed
    [J]. FISH & SHELLFISH IMMUNOLOGY, 2017, 65 : 136 - 144
  • [7] Alexandrov PN, 2005, J ALZHEIMERS DIS, V8, P117
  • [8] β-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system
    Almeida, CG
    Takahashi, RH
    Gouras, GK
    [J]. JOURNAL OF NEUROSCIENCE, 2006, 26 (16) : 4277 - 4288
  • [9] Potential of Nanocarrier-Based Drug Delivery Systems for Brain Targeting: A Current Review of Literature
    Alotaibi, Badriyah Shadid
    Buabeid, Manal
    Ibrahim, Nihal Abdalla
    Kharaba, Zelal Jaber
    Ijaz, Munazza
    Noreen, Sobia
    Murtaza, Ghulam
    [J]. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2021, 16 : 7517 - 7533
  • [10] Chaperone-Mediated Autophagy Markers in Parkinson Disease Brains
    Alvarez-Erviti, Lydia
    Rodriguez-Oroz, Maria C.
    Cooper, J. Mark
    Caballero, Cristina
    Ferrer, Isidro
    Obeso, Jose A.
    Schapira, Anthony H. V.
    [J]. ARCHIVES OF NEUROLOGY, 2010, 67 (12) : 1464 - 1472